Healixia News - page 35

October 30, 2020

Influenza vaccine: absolute priority for protection of most vulnerable people

Source: FAMHP

Griepvaccin: absolute prioriteit voor bescherming meest kwetsbare mensen

Vaccination contre la grippe: priorité absolue pour protéger les personnes les plus vulnérables

October 29, 2020

Submission of dossiers during end-of-year period: final date is 15 December, except for COVID-19 dossiers

Source: FAMHP

During the end-of-year period the FAMHP will be closed from Friday 25 December 2020 up to and including Sunday 3 January 2021. Deadlines have been set for the submission of different types of files.

October 29, 2020

Flash VIG-news: ESMYA® (ulipristal acetate 5 mg): revocation of the marketing authorisation

Source: FAMHP

After reviewing the benefit-risk ratio of the medicinal product ESMYA®, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) has recommended the definitive revocation of its marketing authorisation (MA).

October 29, 2020

Coronavirus: further extension of the measures taken by the FAMHP to avoid medicinal product shortages

Source: FAMHP

On 1 April 2020, the FAMHP took steps regarding a range of medicinal products in order to avoid any shortage. These measures have now been extended by one month.

October 27, 2020

New ESVAC report: antibiotic use continues to decline in animal husbandry in Europe.

Source: FAMHP

The European Medicines Agency (EMA) published the tenth ESVAC report (European Surveillance of Veterinary Antimicrobial Consumption) about the sale of antibacterial agents for veterinary use in 2018. Further efforts remain necessary, in Belgium as well.

October 22, 2020

Influenza vaccines: the FAMHP conducts a survey of all pharmacies.

Source: FAMHP

Griepvaccins: het FAGG doet een bevraging bij alle apotheken

Vaccins contre la grippe: l'AFMPS mène une enquête auprès de toutes les pharmacies

October 20, 2020

Coronavirus: Belgium agrees on procurement of Janssen's (Johnson & Johnson) vaccine candidate

Source: FAMHP

The European Commission is holding negotiations on behalf of the Member States for procurement procedures for COVID-19 vaccines and is presenting contracts to the Member States. In Belgium, the Advisory Committee responsible for the analysis of the procurement files issued a positive recommendation for Janssen's (Johnson & Johnson) vaccine candidate. The Interministerial Conference (IMC) for Public Health has followed the advice. Belgium will buy the vaccine when the it is authorised.

October 15, 2020

Influenza vaccine: another million doses are on the way and will be distributed to pharmacies at the end of October, beginning of November.

Source: FAMHP

Griepvaccin: nog een miljoen dosissen zijn op komst en zullen eind oktober, begin november worden verdeeld naar de apotheken

Vaccin contre la grippe : un million de doses sont encore prévues et seront distribuées dans les pharmacies fin octobre, début novembre

October 15, 2020

Limited availability of the Pneumovax 23® vaccine: recommendations for prescribers, (hospital) pharmacists and wholesalers

Source: FAMHP

Beperkte beschikbaarheid van het vaccin Pneumovax 23®: aanbevelingen aan voorschrijvers, (ziekenhuis)apothekers en groothandelaars

Disponibilité limitée du vaccin Pneumovax 23® : recommandations aux prescripteurs, aux pharmaciens (hospitaliers) et aux grossistes

October 9, 2020

Influenza vaccine: 10% already delivered to the patient, two-thirds still to be delivered to the (hospital) pharmacies.

Source: FAMHP

Griepvaccin: al 10 % afgeleverd aan de patiënt, twee derden moet nog aan de (ziekenhuis)apotheken worden geleverd

Vaccin contre la grippe : déjà 10 % des stocks livrés au patient, les deux tiers restent à livrer aux pharmacies (hospitalières)